The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats.
about
The addition of vildagliptin to metformin prevents the elevation of interleukin 1ß in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study.Role of perivascular adipose tissue on vascular reactive oxygen species in type 2 diabetes: a give-and-take relationship.Rivaroxaban, a factor Xa inhibitor, improves neovascularization in the ischemic hindlimb of streptozotocin-induced diabetic mice.Circulating interleukin-1β promotes endoplasmic reticulum stress-induced myocytes apoptosis in diabetic cardiomyopathy via interleukin-1 receptor-associated kinase-2Disruption of Fractalkine Signaling Leads to Microglial Activation and Neuronal Damage in the Diabetic Retina.Interleukin-1 Receptor Activation Potentiates Salt Reabsorption in Angiotensin II-Induced Hypertension via the NKCC2 Co-transporter in the Nephron.Interleukin-1β mediates high glucose induced phenotypic transition in human aortic endothelial cells.Berberine alleviates the cerebrovascular contractility in streptozotocin-induced diabetic rats through modulation of intracellular Ca²⁺ handling in smooth muscle cells.Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway.The Angiotensin-(1-7)/Mas Axis Counteracts Angiotensin II-Dependent and -Independent Pro-inflammatory Signaling in Human Vascular Smooth Muscle CellsFractalkine Signaling Attenuates Perivascular Clustering of Microglia and Fibrinogen Leakage during Systemic Inflammation in Mouse Models of Diabetic Retinopathy.The IL-1β phenomena in neuroinflammatory diseases.IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus.The antioxidant edaravone prevents cardiac dysfunction by suppressing oxidative stress in type 1 diabetic rats and in high-glucose-induced injured H9c2 cardiomyoblasts.Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation:Cellular and Molecular Mechanisms of Diabetic Atherosclerosis: Herbal Medicines as a Potential Therapeutic Approach.Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells.Supplemental N-acetylcysteine and other measures that boost intracellular glutathione can downregulate interleukin-1β signalling: a potential strategy for preventing cardiovascular events?Resveratrol defends blood-brain barrier integrity in experimental autoimmune encephalomyelitis mice.Interleukin 1 gene polymorphism and susceptibility to disease.Salidroside improved cerebrovascular vasodilation in streptozotocin-induced diabetic rats through restoring the function of BKCa channel in smooth muscle cells.Dual Effects of Resveratrol on Cell Death and Proliferation of Colon Cancer Cells.Stromal-epithelial lactate shuttle induced by tumor‑derived interleukin‑1β promotes cell proliferation in oral squamous cell carcinoma.Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence.Role of Inflammation in Diabetic Retinopathy.Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications.Inflammasome-Independent NALP3 Contributes to High-Salt Induced Endothelial Dysfunction
P2860
Q33716972-34A2D988-FD0B-474B-B3BB-BA9E1BD93FB6Q35630866-3F7D8CB0-3739-4006-B3F6-7D3634E94B87Q35759361-410AA332-D1C7-4FE3-88AA-FBD9E0D17CD7Q35783965-AD350673-FD74-4FC0-92C4-2F18F5689C4CQ36271043-3B94BF17-D6B9-4BC8-9692-9E5325AE8221Q36568185-E5B3B055-7ED1-4E07-94AD-93DB4AD5E9B1Q36654322-F22A55A6-33F9-477B-8381-E0DC6015256CQ36790209-BD2D6FBC-3D6C-4AF8-A52B-12F7EE99FF5AQ36955142-3631C3B6-FB32-42EA-8DF5-E811FB7250F2Q37503859-46F7582E-EFE8-4493-BB74-53F476D8944FQ37574967-96681B6E-1DE4-47C0-A063-37E7184B6FE5Q39324087-0BD854A7-1E36-45FA-9DD3-C4F88D78518FQ39403443-65313A5F-E910-49B0-9A0B-2E5A3748C9ACQ39633634-EF23255B-F1A6-4FFA-815A-0BA63EFACE49Q40815110-27742C31-694B-4039-B5B6-8ED063548B27Q41528907-3B3773B6-C3B7-469F-BF27-654887328EAEQ42145401-85046D94-9DAC-4FF9-A1C3-95D2DCABCD83Q42351011-851F2FF7-E180-462D-A54A-3F5D78AD7D90Q42738285-F00024DD-279C-4D03-B883-42CC58097994Q47653353-F983CD38-E5BA-4811-A789-E6A65F62A441Q47959397-6D42025A-1DE0-4801-832C-D39ABD5D5F69Q49924391-E63C26CE-06AC-41DD-AA97-958C24BAC3F5Q50066233-F9A24B3E-7CC5-4DE5-BB0A-DC7B077DC951Q50074049-F4F86FDE-1849-4BDB-8E90-AEC494426B93Q52642996-92EE1BB4-53C0-4A47-979B-E1AF67A50FE5Q54260312-6EB8CCAB-BC3A-4664-A611-81520CCA3D6DQ58719204-7678605E-9806-4411-8334-C4A0BAEB87F0
P2860
The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The interleukin-1 receptor ant ...... zotocin-induced diabetic rats.
@ast
The interleukin-1 receptor ant ...... zotocin-induced diabetic rats.
@en
The interleukin-1 receptor ant ...... zotocin-induced diabetic rats.
@nl
type
label
The interleukin-1 receptor ant ...... zotocin-induced diabetic rats.
@ast
The interleukin-1 receptor ant ...... zotocin-induced diabetic rats.
@en
The interleukin-1 receptor ant ...... zotocin-induced diabetic rats.
@nl
prefLabel
The interleukin-1 receptor ant ...... zotocin-induced diabetic rats.
@ast
The interleukin-1 receptor ant ...... zotocin-induced diabetic rats.
@en
The interleukin-1 receptor ant ...... zotocin-induced diabetic rats.
@nl
P2093
P2860
P1476
The interleukin-1 receptor ant ...... zotocin-induced diabetic rats.
@en
P2093
Carlos F Sánchez-Ferrer
Erika Palacios
Laura Villalobos
Susana Vallejo
P2860
P2888
P356
10.1186/S12933-014-0158-Z
P407
P577
2014-12-18T00:00:00Z
P5875
P6179
1051583098